OGI

Organigram Recognized for Executive Gender Diversity by the Globe & Mail’s Women Lead Here Report for the Fourth Consecutive Year

Retrieved on: 
Monday, April 8, 2024

Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”), a leading licensed producer of cannabis, is pleased to announce it has been recognized on the 2024 Report on Business ‘Women Lead Here’ list for gender diversity.

Key Points: 
  • Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”), a leading licensed producer of cannabis, is pleased to announce it has been recognized on the 2024 Report on Business ‘Women Lead Here’ list for gender diversity.
  • Fifty percent of the Company’s executive leadership team, including its CEO, are women.
  • The Women Lead Here benchmark was established in 2020 and applies a proprietary research methodology to provide an overview of the largest Canadian corporations with the highest degree of gender diversity among executive ranks.
  • “We are thrilled to be recognized yet again by the Globe & Mail for the gender diversity within our leadership team.

Organigram’s Popular SHRED Brand Surpasses $200 Million in Yearly Retail Sales

Retrieved on: 
Wednesday, April 3, 2024

By being the first to market with this innovation, SHRED swiftly captured the attention of consumers seeking convenience, quality, flavour and value.

Key Points: 
  • By being the first to market with this innovation, SHRED swiftly captured the attention of consumers seeking convenience, quality, flavour and value.
  • From there, the brand expanded to include other popular as well as innovative product categories such as pre-rolls, infused pre-rolls, gummies, and hash, with its patent-pending, award winning Rip-Strip hash.
  • “Underpinning SHRED’s great product lineup is its unique brand positioning, one that continues to resonate deeply with cannabis consumers across the country, " said Tim Emberg, Chief Commercial Officer of Organigram.
  • "Back in 2020, we recognized an untapped niche in the industry and seized the opportunity to build and deliver a bold new brand that set us apart from the competition.

Organigram Successfully Closes Previously Announced Underwritten Public Offering

Retrieved on: 
Tuesday, April 2, 2024

Organigram Holdings Inc. (“Organigram” or the “Company”) (TSX: OGI; NASDAQ: OGI) announces today the closing of its previously announced underwritten public offering of units of the Company (the “Units”) for total gross proceeds of C$28,750,230 (the “Offering”).

Key Points: 
  • Organigram Holdings Inc. (“Organigram” or the “Company”) (TSX: OGI; NASDAQ: OGI) announces today the closing of its previously announced underwritten public offering of units of the Company (the “Units”) for total gross proceeds of C$28,750,230 (the “Offering”).
  • Canada Investments ULC (together with ATB, the “Underwriters”) acted as the underwriters for the Offering.
  • The Company expects to use the net proceeds from the Offering to fund growth initiatives and for general corporate purposes.
  • The Prospectus Supplement, the Base Shelf Prospectus and the Registration Statement contain important detailed information about the Company and the Offering.

Organigram Announces Pricing of Overnight Marketed Public Offering

Retrieved on: 
Wednesday, March 27, 2024

Organigram Holdings Inc. (“Organigram” or the “Company”) (TSX: OGI; NASDAQ: OGI), announces today that, in connection with its previously announced overnight marketed public offering of units of the Company (the “Units”), it has entered into an underwriting agreement with ATB Securities Inc., as lead underwriter, on behalf of itself and a syndicate of underwriters to sell 7,740,000 Units at a price of C$3.23 per Unit (the “Offering Price”) for total gross proceeds of approximately C$25 million (the “Offering”).

Key Points: 
  • Organigram Holdings Inc. (“Organigram” or the “Company”) (TSX: OGI; NASDAQ: OGI), announces today that, in connection with its previously announced overnight marketed public offering of units of the Company (the “Units”), it has entered into an underwriting agreement with ATB Securities Inc., as lead underwriter, on behalf of itself and a syndicate of underwriters to sell 7,740,000 Units at a price of C$3.23 per Unit (the “Offering Price”) for total gross proceeds of approximately C$25 million (the “Offering”).
  • The Company expects to use the net proceeds from the Offering to fund growth initiatives and for general corporate purposes.
  • 333-274686) (the “Registration Statement”) under the United States/Canada Multi-Jurisdictional Disclosure System which includes the Base Shelf Prospectus.
  • The Prospectus Supplement, the Base Shelf Prospectus and the Registration Statement contain important detailed information about the Company and the Offering.

Organigram Invests in U.S. Based Open Book Extracts Representing Inaugural Jupiter Investment

Retrieved on: 
Tuesday, March 26, 2024

Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”) is pleased to announce a US $2 million minority investment in Steady State LLC (d/b/a Open Book Extracts) (“OBX”) in the form of a convertible note.

Key Points: 
  • Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”) is pleased to announce a US $2 million minority investment in Steady State LLC (d/b/a Open Book Extracts) (“OBX”) in the form of a convertible note.
  • “We are extremely excited to make our first Jupiter pool investment in Open Book Extracts, a company that we’ve had on our radar for quite some time,” said Paolo De Luca, Chief Strategy Officer of Organigram.
  • The investment in OBX provides a further footprint in the U.S, which was a strategic priority set out in the Jupiter investment strategy.
  • Through its investment in OBX, Organigram will gain valuable insights into the U.S. market and its consumers.

Organigram Announces Launch of Overnight Marketed Public Offering

Retrieved on: 
Tuesday, March 26, 2024

Organigram Holdings Inc. (“Organigram” or the “Company”) (TSX: OGI; NASDAQ: OGI), announces today an overnight marketed public offering of units of the Company (the “Units”) for total gross proceeds of approximately C$25 million (the “Offering”).

Key Points: 
  • Organigram Holdings Inc. (“Organigram” or the “Company”) (TSX: OGI; NASDAQ: OGI), announces today an overnight marketed public offering of units of the Company (the “Units”) for total gross proceeds of approximately C$25 million (the “Offering”).
  • The Offering will be made in the United States through the lead underwriter's U.S. affiliate, ATB Capital Markets USA Inc.
  • There can be no assurance as to whether or when the Offering may be completed, or as to the actual size or terms of the Offering.
  • The Prospectus Supplement, the Base Shelf Prospectus and the Registration Statement contain important detailed information about the Company and the Offering.

Sitka Gold Provides Update on its North American Gold, Silver and Copper Assets

Retrieved on: 
Thursday, March 14, 2024

VANCOUVER, BC, March 14, 2024 /PRNewswire/ - Sitka Gold Corp. ("Sitka" or the "Company") (TSXV:SIG) (FSE:1RF) (OTCQB:SITKF) is pleased to provide project updates for its portfolio of Gold, Silver and Copper properties located in proven, mining friendly jurisdictions in North America (see Figure 1).

Key Points: 
  • VANCOUVER, BC, March 14, 2024 /PRNewswire/ - Sitka Gold Corp. ("Sitka" or the "Company") (TSXV:SIG) (FSE:1RF) (OTCQB:SITKF) is pleased to provide project updates for its portfolio of Gold, Silver and Copper properties located in proven, mining friendly jurisdictions in North America (see Figure 1).
  • Sitka's project portfolio includes the RC Gold project ("RC Gold") and OGI project ("OGI") located in Yukon, the Alpha Gold project ("Alpha Gold") located in Nevada, the Burro Creek project ("Burro Creek") located in Arizona and the Coppermine River project ("Coppermine River") located in Nunavut.
  • Sitka Gold Corp. is a well-funded mineral exploration company headquartered in Canada with approximately $7.5 million in the treasury.
  • Hole 47 contained the best gold mineralized intersection to date on the property, returning 219.0 m of 1.34 g/t gold including 124.8 m of 2.01 g/t gold and 55.0m of 3.11 g/t gold.

Organigram Applauds the Standing Committee on Finance’s Recommendation on Excise Duty

Retrieved on: 
Wednesday, February 28, 2024

Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”) enthusiastically supports the Standing Committee on Finance’s recent recommendation on the Excise Duty framework.

Key Points: 
  • Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”) enthusiastically supports the Standing Committee on Finance’s recent recommendation on the Excise Duty framework.
  • In a recently released report, titled ‘Shaping our Economic Future: Canadian Priorities,’ the House of Commons Standing Committee on Finance has unanimously recommended adjusting the excise duty formula for cannabis so that it is limited to a 10% ad valorem rate, and modifying the duty's operation, including applying excise stamps on cannabis products.
  • “The pre-budget recommendation could not have come at a better time,” said Beena Goldenberg, CEO of Organigram.
  • “Excise reform is critical to the long-term viability of the Canadian cannabis industry.

Organigram Reports First Quarter Fiscal 2024 Results

Retrieved on: 
Tuesday, February 13, 2024

Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”), a leading licensed producer of cannabis, announced its results for the first quarter ended December 31, 2023 (“Q1 Fiscal 2024”).

Key Points: 
  • Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”), a leading licensed producer of cannabis, announced its results for the first quarter ended December 31, 2023 (“Q1 Fiscal 2024”).
  • View the full release here: https://www.businesswire.com/news/home/20240213404480/en/
    “We certainly kicked off fiscal 2024 with a bang", said Beena Goldenberg, Chief Executive Officer.
  • Q1 Fiscal 2024 saw the introduction of 22 new SKUs to the market for Organigram.
  • In December 2023, we had a record breaking month in shipped recreational sales, stemming from consistent market share gains throughout Q1 Fiscal 2024."

Organigram to Report First Quarter Fiscal 2024 Results on February 13, 2024

Retrieved on: 
Wednesday, February 7, 2024

Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (together, the “Company” or “Organigram”), a leading licensed producer of cannabis, announced today it will report earnings results for its first quarter fiscal 2024 ended December 31, 2023, on Tuesday, February 13, 2024, prior to market open.

Key Points: 
  • Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (together, the “Company” or “Organigram”), a leading licensed producer of cannabis, announced today it will report earnings results for its first quarter fiscal 2024 ended December 31, 2023, on Tuesday, February 13, 2024, prior to market open.
  • After registering, a confirmation will be sent through email, including dial in details and unique conference call codes for entry.
  • Participants will receive their details via email.
  • A replay of the webcast will be available within 24 hours after the conclusion of the call at https://www.organigram.ca/investors and will be archived for a period of 90 days following the call.